📢 New: get today's jobs on our WhatsApp Channel
Jobiglo

No results.

Market Access Trainee (Apprenticeship) – France/Belgium

astrazeneca

New
Junior 🇬🇧 English

Job description

About the role

Alexion, a global biopharmaceutical company focused on rare diseases, is recruiting a Market Access apprentice to join its small France/Belgium subsidiary team. The apprentice will help develop and deploy the market access strategy in France and Belgium, starting in September 2025. The trainee will be exposed to varied and cross-functional projects.

Key responsibilities

  • Analyze prices, reimbursement schemes and benchmarks
  • Take part in building market access dossiers for France and Belgium
  • Contribute to developing economic models
  • Evaluate risks and opportunities
  • Monitor competition, the regulatory environment and health policy trends

Required profile

  • Scientific degree (engineer, pharmacist or doctor)
  • Currently studying a Master's in Market Access / health economics
  • Fluent spoken and written English
  • Ability to analyse and synthesise information
  • Proactive, rigorous, curious and team-oriented

Questions fréquentes

Le salaire n'est pas communiqué publiquement par le recruteur. Vous pouvez postuler et négocier directement avec astrazeneca.
Cliquez sur "Postuler maintenant" en haut de la page. Vous pouvez importer votre CV en 1 clic — Jobiglo extrait automatiquement vos informations et postule pour vous.
Source : ats:workday

Why are you reporting this job?

Thank you for your report. We will review this job.

Apply in 30 seconds

Enter your email to apply. An account will be created automatically.

Apply now →

By continuing, you accept our terms of use.

Already have an account? Login

A question about this job?

Ask it here: you will get the full job summary by e-mail, right away.

💬 Chat with us on Telegram

Published 3 hours ago

Expires 1 month from now

5 views · 0 interested

Boost your chances

Upload your CV — we will match you with relevant openings.

Analyzing your CV...

astrazeneca